olivier muller
olivier muller
Full professor at University of Lausanne
Verified email at
Cited by
Cited by
Prognostic value of fractional flow reserve: linking physiologic severity to clinical outcomes
NP Johnson, GG Tóth, D Lai, H Zhu, G Açar, P Agostoni, Y Appelman, ...
Journal of the American College of Cardiology 64 (16), 1641-1654, 2014
Long-term clinical outcome after fractional flow reserve–guided treatment in patients with angiographically equivocal left main coronary artery stenosis
M Hamilos, O Muller, T Cuisset, A Ntalianis, G Chlouverakis, G Sarno, ...
Circulation 120 (15), 1505-1512, 2009
Gut microbiota-dependent trimethylamine N-oxide in acute coronary syndromes: a prognostic marker for incident cardiovascular events beyond traditional risk factors
XS Li, S Obeid, R Klingenberg, B Gencer, F Mach, L Räber, S Windecker, ...
European heart journal 38 (11), 814-824, 2017
Fractional flow reserve for the assessment of nonculprit coronary artery stenoses in patients with acute myocardial infarction
A Ntalianis, JW Sels, G Davidavicius, N Tanaka, O Muller, C Trana, ...
JACC: Cardiovascular Interventions 3 (12), 1274-1281, 2010
Evolving concepts of angiogram: fractional flow reserve discordances in 4000 coronary stenoses
G Toth, M Hamilos, S Pyxaras, F Mangiacapra, O Nelis, F De Vroey, ...
European heart journal 35 (40), 2831-2838, 2014
Nonmyocardial production of ST2 protein in human hypertrophy and failure is related to diastolic load
J Bartunek, L Delrue, F Van Durme, O Muller, F Casselman, B De Wiest, ...
Journal of the American College of Cardiology 52 (25), 2166-2174, 2008
Ultrathin strut biodegradable polymer sirolimus-eluting stent versus durable polymer everolimus-eluting stent for percutaneous coronary revascularisation (BIOSCIENCE): a …
T Pilgrim, D Heg, M Roffi, D Tüller, O Muller, A Vuilliomenet, S Cook, ...
The Lancet 384 (9960), 2111-2122, 2014
Comparison of everolimus-and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds
S Puricel, D Arroyo, N Corpataux, G Baeriswyl, S Lehmann, Z Kallinikou, ...
Journal of the American College of Cardiology 65 (8), 791-801, 2015
Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)
KC Koskinas, S Windecker, G Pedrazzini, C Mueller, S Cook, CM Matter, ...
Journal of the American College of Cardiology 74 (20), 2452-2462, 2019
Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes
D Nanchen, B Gencer, R Auer, L Räber, GG Stefanini, R Klingenberg, ...
European heart journal 36 (36), 2438-2445, 2015
CardioVerse: The cardiovascular medicine in the era of Metaverse
I Skalidis, O Muller, S Fournier
Trends in cardiovascular medicine 33 (8), 471-476, 2023
Biodegradable polymer sirolimus-eluting stents versus durable polymer everolimus-eluting stents in patients with ST-segment elevation myocardial infarction (BIOSTEMI): a single …
JF Iglesias, O Muller, D Heg, M Roffi, DJ Kurz, I Moarof, D Weilenmann, ...
The Lancet 394 (10205), 1243-1253, 2019
Mineralocorticoid Effects in the Kidney: Correlation between αENaC, GILZ, and Sgk-1 mRNA Expression and Urinary Excretion of Na:+: and K:+
OG Muller, RG Parnova, G Centeno, BC Rossier, D Firsov, ...
Journal of the American Society of Nephrology 14 (5), 1107-1115, 2003
Translesional pressure gradients to predict blood pressure response after renal artery stenting in patients with renovascular hypertension
F Mangiacapra, C Trana, G Sarno, G Davidavicius, M Protasiewicz, ...
Circulation: Cardiovascular Interventions 3 (6), 537-542, 2010
Prognosis of patients with familial hypercholesterolemia after acute coronary syndromes
D Nanchen, B Gencer, O Muller, R Auer, S Aghlmandi, D Heg, ...
Circulation 134 (10), 698-709, 2016
Long-term follow-up after fractional flow reserve–guided treatment strategy in patients with an isolated proximal left anterior descending coronary artery stenosis
O Muller, F Mangiacapra, A Ntalianis, KMC Verhamme, C Trana, ...
JACC: Cardiovascular Interventions 4 (11), 1175-1182, 2011
Intracoronary adenosine: dose–response relationship with hyperemia
J Adjedj, GG Toth, NP Johnson, M Pellicano, A Ferrara, V Floré, ...
Cardiovascular Interventions 8 (11), 1422-1430, 2015
Stress perfusion CMR in patients with known and suspected CAD: prognostic value and optimal ischemic threshold for revascularization
G Vincenti, PG Masci, P Monney, T Rutz, S Hugelshofer, M Gaxherri, ...
JACC: Cardiovascular Imaging 10 (5), 526-537, 2017
Ultrathin-strut, biodegradable-polymer, sirolimus-eluting stents versus thin-strut, durable-polymer, everolimus-eluting stents for percutaneous coronary revascularisation: 5 …
T Pilgrim, R Piccolo, D Heg, M Roffi, D Tüller, O Muller, I Moarof, ...
The Lancet 392 (10149), 737-746, 2018
Interference of drug-eluting stents with endothelium-dependent coronary vasomotion: evidence for device-specific responses
M Hamilos, J Sarma, M Ostojic, T Cuisset, G Sarno, N Melikian, ...
Circulation: Cardiovascular Interventions 1 (3), 193-200, 2008
The system can't perform the operation now. Try again later.
Articles 1–20